TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer (Q36145430)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer |
scientific article |
Statements
1 reference
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer (English)
1 reference
1 reference
Hope S Rugo
1 reference
Minetta C Liu
1 reference
Eric P Winer
1 reference
Katherine A Hoadley
1 reference
Timothy J Hobday
1 reference
Lisa A Carey
1 reference
P Kelly Marcom
1 reference
Erica L Mayer
1 reference
Francisco J Esteva
1 reference
Cynthia X Ma
1 reference
Anna Maria Storniolo
1 reference
Mothaffar F Rimawi
1 reference
Andres Forero-Torres
1 reference
Antonio C Wolff
1 reference
Anastasia Ivanova
1 reference
Wing-Keung Chiu
1 reference
Madlyn Ferraro
1 reference
Emily Burrows
1 reference
Philip S Bernard
1 reference
4 June 2012
1 reference
1 reference
2615-2623
1 reference
Identifiers
1 reference
1 reference
1 reference